Psykey (CEOS) Stock Price, News & Analysis

Company Overview

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

Key Stats

• Today's Range: $0.0066 to $0.0090
• 50-Day Range: $0.0069 to $0.0145
• 52-Week Range: $0.00 to $0.04
• Volume: 120,800 shs
• Average Volume: 494,106 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CEOS Stock Analysis - Frequently Asked Questions

How have CEOS shares performed this year?

Psykey's stock was trading at $0.0390 at the beginning of 2025. Since then, CEOS stock has decreased by 78.5% and is now trading at $0.0084.

How do I buy shares of Psykey?

Shares of CEOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Psykey own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Psykey investors own include Fernhill (FERN), Iconic Minerals (ICM), Puget Technologies (PUGE), Tonix Pharmaceuticals (TNXP), Amazonas Florestal (AZFL), Ayr Strategies (AYRSF) and Anavex Life Sciences (AVXL).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: Wholesale
• Current Symbol: OTCMKTS:CEOS
• CIK: N/A
• Web: www.cecorsinc.com
• Phone: (877) 348-1155
• Fax: N/A
• Employees: 6
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A